Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Narrative) (Details)

v3.22.0.1
Subsequent Events (Narrative) (Details) - Subsequent Event [Member] - USD ($)
Feb. 09, 2022
Jan. 16, 2022
Stock Options [Member] | Consultants [Member]    
Subsequent Event [Line Items]    
Number of options granted   30,000
Weighted-average exercise price per share   $ 0.52
Vesting period   1 year
Share based payment plan term   10 years
Settled Litigation [Member] | iBio, Inc. v. Fraunhofer USA, Inc. [Member]    
Subsequent Event [Line Items]    
Payment received under the license agreement with FhUSA $ 900,000